Page 25 - GPD-3-4
P. 25

Gene & Protein in Disease                                          GLUT5 in cancer development and therapy




































            Figure 2. Illustration of pathways and key players of fructose metabolism inducing cancer cell proliferation and tumor growth. Created with Biorender.com

            DHAP can also enter the glycolysis pathway and be   Fructose-induced PPP process also causes inflationary
            converted to glyceraldehyde-3-phosphate. Alternatively,   effects in cells,  and dysregulation of the PPP process
                                                                           29
            fructose can be phosphorylated at C6 position by HK in   contributed greatly in malignant tumors. 30,31
            muscle or fat tissue, entering glycolysis directly. However,
            this process is not efficient because the affinity of HK to   2.2. Increased tumor growth and survival
            glucose is higher than fructose. In addition, excess fructose   The key to fructose uptake and metabolism is the
            can be converted into acetyl-CoA, a substrate for fatty acid   expression of GLUT5 in cancer cells as demonstrated
            synthesis. An in vivo study by Goncalves et al.  reported   by  numerous  studies.  For  example, a  study  by  Jin
                                                  26
            a  substantial  increase  in tumor size  and  tumor  grade   et  al.  suggested a direct correlation between GLUT5
                                                                    32
            of intestinal tumor in mice fed with high-fructose corn   expression and the proliferation of the ovarian cancer
            syrup. The tumor growth was attributed to the activation   cells in fructose-rich growth medium. The animal
            of glycolysis and increased lipogenesis by F1P.    experiments  also showed that high fructose  intake
              In addition to the impacts on glycolysis, the glycolytic   significantly  increased  tumor  volume.  In  another
                                                                    10
            intermediates of fructose metabolism in cancer cells   study,  the blockade of GLUT5 with the inhibitor,
            increase PPP activity,  a metabolic pathway parallel to   N-[4-(methylsulfonyl)-2-nitrophenyl]-1,3-benzodioxol-
                              27
            glycolysis. The PPP process generates NADPH and ribose-  5-amine significantly decreased the viability of colon
            5-phosphate. The NADPH is essential for maintaining the   cancer cells, but had marginal effects on the viability of
            redox balance and biosynthesis, such as lipid biosynthesis,   normal  colon epithelium  cells, suggesting  the critical
            while ribose-5-phosphate is critical for nucleotide synthesis,   role of GLUT5 in cancer cell proliferation. The direct
            supporting DNA replication and repair in proliferating   correlation of GLUT5 expression and enhanced fructose
                      28
            cancer  cells.   Increased  lipogenesis  is necessary  for  the   uptake and tumor progression was also observed in
            formation of cell membranes in proliferating cancer cells.   glioma.  In addition, GLUT5 knockdown significantly
                                                                     12
            Many cancer cells exhibited increased PPP activity to meet   inhibited the proliferation of glioma cells in fructose
            their high demand for NADPH and ribose-5-phosphate.   medium. Another study by Carreño  et al.  not only
                                                                                                    13
            The  enhanced  NADPH  production  helps  to  maintain   demonstrated that GLUT5-regulated fructose uptake
            cellular  antioxidants  (e.g.,  glutathione).  This  reduces   stimulated proliferation and invasion of prostate cancer
            oxidative stress and protects cancer cells from apoptosis,   cells in vitro, and increased the growth of patient-derived
            supporting can cell survival and continued proliferation.   xenograft tumors but also confirmed the upregulation of


            Volume 3 Issue 4 (2024)                         4                               doi: 10.36922/gpd.4171
   20   21   22   23   24   25   26   27   28   29   30